Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a …
JA Kahn, LE Widdice, L Ding, B Huang… - Clinical Infectious …, 2016 - academic.oup.com
abstract Background. Human papillomavirus (HPV) vaccine effectiveness and herd
protection are not well established in community settings. Our objective was to determine …
protection are not well established in community settings. Our objective was to determine …
Human papillomavirus vaccine effectiveness and herd protection in young women
C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - publications.aap.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition …
LE Markowitz, S Hariri, C Lin, EF Dunne… - The Journal of …, 2013 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination was introduced into the routine
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction
JA Kahn, DR Brown, L Ding, LE Widdice, ML Shew… - …, 2012 - publications.aap.org
OBJECTIVES: The aims of this study were to compare prevalence rates of human
papillomavirus (HPV) in young women before and after HPV vaccine introduction to …
papillomavirus (HPV) in young women before and after HPV vaccine introduction to …
Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
Non–vaccine-type human papillomavirus prevalence after vaccine introduction: No evidence for type replacement but evidence for cross-protection
M Saccucci, EL Franco, L Ding… - Sexually transmitted …, 2018 - journals.lww.com
Background We examined non–vaccine-type human papillomavirus (HPV) prevalence in a
community before and during the first 8 years after vaccine introduction, to assess for (1) …
community before and during the first 8 years after vaccine introduction, to assess for (1) …
Incidence and types of human papillomavirus infections in adolescent girls and young women immunized with the human papillomavirus vaccine
NF Schlecht, A Diaz, A Nucci-Sack… - JAMA Network …, 2021 - jamanetwork.com
Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination
DA Machalek, SM Garland… - The Journal of …, 2018 - academic.oup.com
Introduction A quadrivalent human papillomavirus vaccination program targeting females
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009–2012
AB Berenson, TH Laz, M Rahman - The Journal of Infectious …, 2016 - academic.oup.com
Between 2009 and 2012, the proportion of young women in the United States completing
the human papillomavirus (HPV) vaccine doubled. To understand how quickly this …
the human papillomavirus (HPV) vaccine doubled. To understand how quickly this …
Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses
LE Markowitz, AL Naleway, NP Klein… - The Journal of …, 2020 - academic.oup.com
Background Highly effective human papillomavirus (HPV) vaccines are used in many
national programs in 3-or 2-dose schedules. We examined HPV vaccine effectiveness …
national programs in 3-or 2-dose schedules. We examined HPV vaccine effectiveness …